Literature DB >> 21358675

MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).

R Wang1, Z-X Wang, J-S Yang, X Pan, W De, L-B Chen.   

Abstract

Accumulating evidence suggests that microRNAs (miRNAs) are important gene regulators, which can have critical roles in diverse biological processes including tumorigenesis. In this study, we analyzed the miRNA expression profiles in non-small cell lung carcinoma (NSCLC) by use of a miRNA microarray platform and identified 40 differentially expressed miRNAs. We showed that miRNA (miR)-451 was the most downregulated in NSCLC tissues. The expression level of miR-451 was found to be significantly correlated with tumor differentiation, pathological stage and lymph-node metastasis. Moreover, low miR-451 expression level was also correlated with shorter overall survival of NSCLC patients (P<0.001). Ectopic miR-451 expression significantly suppressed the in vitro proliferation and colony formation of NSCLC cells and the development of tumors in nude mice by enhancing apoptosis, which might be associated with inactivation of Akt signaling pathway. Interestingly, ectopic miR-451 expression could significantly inhibit RAB14 protein expression and decrease a luciferase-reporter activity containing the RAB14 3'-untranslated region (UTR). In addition,, RNA interference silencing of RAB14 gene could recapitulate the tumor suppressor function of miR-451, whereas restoration of RAB14 expression could partially attenuate the tumor suppressor function of miR-451 in NSCLC cells. Furthermore, we also showed that strong positive immunoreactivity of RAB14 protein was significantly associated with downregulation of miR-451 (P=0.01). These findings suggest that miR-451 regulates survival of NSCLC cells partially through the downregulation of RAB14. Therefore, targeting with the miR-451/RAB14 interaction might serve as a novel therapeutic application to treat NSCLC patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21358675     DOI: 10.1038/onc.2010.642

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  137 in total

1.  MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.

Authors:  Fei Zhang; Wei Huang; Meixia Sheng; Tielong Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  Serum miRNA expression in patients with esophageal squamous cell carcinoma.

Authors:  Beina Hui; Xin Chen; Lingyun Hui; Ruxing Xi; Xiaozhi Zhang
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

3.  MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells.

Authors:  Pin Yin; Rui Peng; Huimin Peng; Li Yao; Yan Sun; Li Wen; Tianhui Wu; Ji Zhou; Zheng Zhang
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

Review 4.  The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells.

Authors:  N Porther; M A Barbieri
Journal:  Small GTPases       Date:  2015-08-20

5.  miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.

Authors:  Xiao Xie; Hongtao Liu; Mingsong Wang; Fangbao Ding; Haibo Xiao; Fengqing Hu; Rui Hu; Ju Mei
Journal:  Tumour Biol       Date:  2015-02-09

6.  Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.

Authors:  Lunxu Liu; Dongxia Ge; Lin Ma; Jiandong Mei; Sen Liu; Qiuyang Zhang; Fuqiang Ren; Hu Liao; Qiang Pu; Tao Wang; Zongbing You
Journal:  J Thorac Oncol       Date:  2012-07       Impact factor: 15.609

7.  FBXO31 promotes cell proliferation, metastasis and invasion in lung cancer.

Authors:  Hai-Li Huang; Yun Jiang; Ya-Hong Wang; Ting Chen; Hui-Juan He; Tie Liu; Teng Yang; La-Wei Yang; Jie Chen; Ze-Qing Song; Weimin Yao; Bin Wu; Gang Liu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

8.  Regulation of gene expression by miR-144/451 during mouse erythropoiesis.

Authors:  Peng Xu; Lance E Palmer; Christophe Lechauve; Guowei Zhao; Yu Yao; Jing Luan; Anastasios Vourekas; Haiyan Tan; Junmin Peng; John D Schuetz; Zissimos Mourelatos; Gang Wu; Mitchell J Weiss; Vikram R Paralkar
Journal:  Blood       Date:  2019-04-10       Impact factor: 22.113

9.  Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.

Authors:  Zheng Chen; Rama Saad; Peilin Jia; DunFa Peng; Shoumin Zhu; M Kay Washington; Zhongming Zhao; Zekuan Xu; Wael El-Rifai
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

10.  MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

Authors:  Jing Liu; Kai-Hua Lu; Zhi-Li Liu; Ming Sun; Wei De; Zhao-Xia Wang
Journal:  BMC Cancer       Date:  2012-11-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.